Category: PSYCH NEWS

Coming This Monday

Microdose’s Wonderland: Miami Conference to be held at the Adrienne Arsht Center for the Performing Arts in Miami, FL on November 7-9, 2021. Wonderland: Miami

Interview: Great Interview With Cybin (CYBN) CEO Doug Drysdale. Interview start at 10:00 mark. LIVE QUOTE It had been a long descent lower for AdvisorShares...

Ehave (EHVVF) Announces Inclusion in the 2021 Psychedelic Investor Guide

MIAMI, Sept. 27, 2021 (GLOBE NEWSWIRE) — Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today that it...

Ehave (EHVVF) Announces Update On Ehave Medical App With The Launch Of Covid Vaccine Passport Going Live Shortly

Ehave's Covid Passport provides small businesses a tool to verify Covid-19 vaccination, and a suite of products to improve both the mental and overall health of individuals.

We Just Got Closer to Understanding Why Ketamine Is Such a Powerful Antidepressant (Science Alert).

CARLY CASSELLA 13 AUGUST 2021 Oral ketamine, known both as an anesthetic and a recreational drug, has recently emerged as a highly promising, rapid treatment for severe depression.

Adding Ehave (EHVVF) to Psychedelic Stock Watch List.

Mental Health and Wellness Incubator Set to Launch Four Initiatives.Trading at Year Low.Launching Clinical Trial With Brain Scientific to Monitor Ketamine Efficacy.Launching Clinical Trial With Mycotopia Therapies and PsyBioMed.Launching...

CBS News: Inside a Psychedelic Ketamine Therapy Sessions (Video).

Therapy Treatment Performed by Ehave’s (EHVVF) Chief Medical Office Dr. Jeffrey Kamlet Received Rave Reviews and Offers the Potential to Save Lives. MIAMI BEACH, Fla. (CBS12) — Last month,...
Most Popular

Awakn Life Sciences (AWKNF) $0.30 Announces Signing of Lease for Second Clinic in Norway.

Trondheim in central Norway will be the location of Awakn's 4th clinic LIVE QUOTE

Silo Pharma (SILO) Issues Letter to Shareholders

Silo Pharma Issues Letter to Shareholders Detailing Progress on Pipeline Assets Combining Traditional Therapeutics with Psychedelic Medicine LIVE QUOTE

Silo Pharma (SILO) $3.36 Achieves New Milestone for SP-26 Therapeutic -Initiates IND Enabling Study of Topical Ketamine Formulation

View Post ENGLEWOOD CLIFFS, NJ, Nov. 11, 2022 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“the Company”), a developmental stage...